Shenzhen People's Hospital: Established Grade 3A Medical Center, Home of Shenzhen Institute of Oncology & Premier Radiation Center

Established in 1946, Shenzhen People's Hospital (SPH / 深圳市人民医院留医部) is the city's historic first and largest municipal Class A Tertiary comprehensive general hospital. Known affectionately across generations as "Liuyibu" (留医部), the hospital also serves as the First Affiliated Hospital of Southern University of Science and Technology (SUSTech) and the Second Clinical Medical College of Jinan University. Situated on Dongmen North Road in Luohu District, SPH is a clinical anchor of the Greater Bay Area, renowned for its extensive clinical scale, multidisciplinary depth, and established cancer care services.

World-Class Clinical Specialties & Breakthrough Strengths

1. ⚡ One of Shenzhen's Largest Radiation Oncology Centers

The Department of Radiation Oncology at SPH is an authoritative clinical base for precision radiation therapy in Shenzhen:

• Advanced Technological Suite: Equipped with multiple high-energy digital linear accelerators, 4D-CT respiratory-gated simulation systems, and volumetric modulated arc therapy (VMAT) capabilities.
• Stereotactic Body Radiotherapy (SBRT): Sub-millimeter stereotactic ablation delivering high curative doses to early lung cancers, liver oligometastases, and spinal/bone lesions while strictly protecting critical adjacent normal organs.
• Comprehensive Radiation Planning: Individualized inverse planning for head and neck cancers, thoracic malignancies, breast cancer post-mastectomy radiation, and pelvic carcinomas.

2. 🫁 Thoracic Oncology (Lung & Esophageal Cancer)

Providing integrated surgical and medical expertise for thoracic malignancies:

• Minimally invasive uniportal Video-Assisted Thoracoscopic Surgery (VATS) and robotic-assisted anatomical lobectomies and segmentectomies for early and locally advanced non-small cell lung cancer (NSCLC).
• Multidisciplinary early pulmonary nodule management clinics utilizing high-resolution low-dose CT (LDCT) and artificial intelligence diagnostic assistance.
• Comprehensive targeted therapy protocols guided by NGS genomic sequencing (EGFR, ALK, ROS1, KRAS) and modern immune-checkpoint inhibitor combinations.

3. 🗣️ Head & Neck Oncology Center

A leading regional surgical referral center for tumors of the head, neck, and upper aerodigestive tract:

• Radical surgical resections for thyroid carcinomas, laryngeal cancer, hypopharyngeal carcinoma, salivary gland tumors, and oral cavity cancers.
• Routine application of endoscopic and cosmetic-incision thyroid surgeries preserving anterior neck aesthetics.
• Microvascular free-flap reconstructive surgery restoring vital swallowing, speech, and masticatory functions after ablative oncologic surgery.

4. 🩺 Comprehensive Routine Oncology & Survivorship Follow-up

SPH is especially recognized as the go-to medical center for routine, continuous cancer care and post-treatment monitoring:

• Full-spectrum subspecialty coverage across gastrointestinal cancer, breast oncology, hepatobiliary surgery, and gynecologic oncology.
• Standardized, protocol-based outpatient chemotherapy, targeted drug administration, and immunotherapy infusion suites.
• Structured long-term cancer survivorship and surveillance programs providing regular periodic CT/MRI imaging, tumor marker kinetics monitoring, and management of chronic treatment-related toxicities.

Integrated Multidisciplinary Team (MDT) System

SPH adheres to structured Multidisciplinary Tumor Boards (MDT) covering all major oncological diseases. Regular collaborative clinical conferences bring together:

• Thoracic, general, head & neck, and breast surgeons
• Radiation oncologists and medical physicists
• Medical oncologists and cancer pharmacologists
• Diagnostic radiologists and nuclear medicine specialists
• Clinical and molecular pathologists

This coordinated panel approach guarantees that patients receive standardized, guideline-concordant therapy from initial staging through to post-treatment maintenance.

Hospital Location & Facilities

• Main Hospital Address (Liuyibu): 1017 Dongmen North Road, Luohu District, Shenzhen, Guangdong, China (深圳市罗湖区东门北路1017号，留医部)
• Hospital Tier: Class A Tertiary Comprehensive General Hospital (国家三级甲等综合性医院)
• Research Base: Shenzhen Institute of Oncology (深圳市肿瘤研究所)
• Cross-Border Accessibility: Centrally located in Luohu District, offering convenient access via high-speed rail and border ports from Hong Kong.

Medical Records Recommended for Specialist Review

Patients seeking specialist consultation, radiotherapy planning, or comprehensive follow-up should prepare:

• Pathology Reports: Formal biopsy histopathology, cytology, and detailed immunohistochemical (IHC) diagnostic stains;
• Diagnostic Imaging: High-resolution CT, MRI, and PET-CT scans provided in raw digital DICOM format along with radiologist reports;
• Prior Radiotherapy Records: Previous radiation treatment charts, target volume delineations, and total cumulative dosage summaries;
• Systemic Treatment Summary: Comprehensive history of chemotherapy, targeted therapy, or immunotherapy regimens with exact agents and dates;
• Longitudinal Tumor Markers: Historical tracking of serum tumor markers (CEA, CA19-9, CA125, AFP, CYFRA21-1, PSA).

Disclaimer: Information on this page regarding Shenzhen People's Hospital (SPH) is compiled from official hospital records, public health directories, and academic medical publications. Clinic availability, physician schedules, and treatment protocols are determined solely by the treating hospital team. Always verify details through official hospital channels or qualified medical specialists.

Notice: China Medical Concierge - Shanghai (CMCS) is an independent health management and medical concierge service provider, not a hospital or clinic. We do not provide direct medical diagnoses or therapeutic procedures. All clinical evaluations and medical treatments are performed independently by licensed physicians at partner hospitals.